Vascutek

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Vascutek sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).

4 total trials 3 currently recruiting upper quartile by trial count

Vascutek: 4 sponsored US clinical trials, 3 recruiting.

Vascutek sponsors 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting. The most-studied condition in this pipeline is Aortic Diseases, with 2 trials.

Upper-quartile sponsor footprint

Vascutek sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

4 total, page 1 of 1

RECRUITING NA

A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta

NCT07078383
RECRUITING

PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches

NCT04545502
RECRUITING

Terumo Aortic Global Endovascular Registry

NCT04246463
ACTIVE NOT RECRUITING

Thoraflex Hybrid and Relay Extension Post-Approval Study

NCT05639400

Therapeutic Areas

Aortic Diseases 2
Aortic Aneurysm 2
Thoracic Aortic Aneurysm 2
Thoracic Aortic Dissection 1
Aorta, Thoracic Pathologies 1
Aneurysmal Disease 1
Aneurysm of Aorta, Thoracic 1
Aortic Aneurysm and Dissection 1
Occlusive Vascular Disease 1
Bypass Extremity Graft 1

What is open in the Vascutek pipeline

3 recruiting of 4 indexed (75% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Aortic Diseases (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Vascutek: open-pipeline peers nationwide

Peers matched on 4 registered trials and 75% open enrollment, not the therapeutic-area sidebar.

Vascutek sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 3.94.04.044.04.04.1 0%20%40%60%80% Total trials Recruiting share Vascutek4D pharma60 Degrees PharmaceuticalsA2 BiotherapeuticsAbdul Latif Jameel Poverty Action LabAcepodia BiotechAmerican Laboratory Products CompanyAmryt PharmaAmydis
Vascutek sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Vascutek sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 4 trials (± recruiting share)

Sponsors near 75% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Vascutek page

4 registered trials is a research-attention snapshot, not an endorsement of Vascutek or any single study.

  • 3 of Vascutek's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Aortic Diseases is the condition Vascutek studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aortic Diseases trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Vascutek pipeline card: 4 registered trials from official public datasets.Report a data error.